Pivotal CAR-T therapy cancer study published in the New England Journal of Medicine

John Theurer Cancer Center is the only New Jersey center that participated in a pivotal clinical trial of a groundbreaking cancer treatment, CAR-T Cell therapy, which genetically modifies a patient’s immune system to attack cancer cells. André Goy, M.D., chairman and director, chief of Lymphoma, and director of Clinical and Translational Cancer Research at John Theurer Cancer Center, is a co-author of the study, presented at the 59th Annual Meeting of the American Society of Hematology and published on December 10, 2017 in the New England Journal of Medicine.

Read full article on